-
Govt issues notification on PLI Scheme with a few amendments
expresspharma
July 23, 2020
Under the PLI Scheme, the industry seeks clarity on the definition of greenfield projects.
-
Govt may allow 30 per cent import of chemicals/intermediates in PLI scheme
expresspharma
July 22, 2020
In the next phase of the PLI scheme, the government has plans to incentivise excipient manufacturers.
-
Glenmark launches hypertension awareness symbol, endorsed by API and HSI
expresspharma
July 20, 2020
Glenmark Pharmaceuticals has launched the world’s first hypertension awareness symbol, in collaboration with the Association of Physicians of India (API) and Hypertension Society of India (HSI).
-
Industry asks govt to take out minimum investment criteria from PLI scheme
expresspharma
July 16, 2020
Pharma stakeholders believe that this modification in the scheme will benefit the industry, patients and the nation in the long run.
-
TIFAC releases report on status, issues, technology readiness and challenges in API production
expresspharma
July 16, 2020
It was released along with a white paper on ‘Focused Interventions for ‘Make in India’: Post COVID 19’ which brought out the strengths, market trends, and opportunities in five sectors, including healthcare.
-
Biophore ramps up Made-In-India Favipiravir production for Covid-19
expresspharma
July 15, 2020
Biophore has received the DCGI license to manufacture the API in India and has been cleared for export as well.
-
CordenPharma Increases U.S. Peptide Manufacturing Capacity
contractpharma
July 09, 2020
Expansion aims to accommodate a large spike in demand for peptide API’s.
-
CNS Pharmaceuticals Completes API Shipments to Manufacturers
contractpharma
July 09, 2020
Supplies active ingredients for the production of Berubicin.
-
Pharma cos should develop strategies to develop APIs and making India self-reliant: Dr Eswara Reddy
expresspharma
June 28, 2020
Companies investing in backward integration, new age technology, etc. would get the preference in the PLI scheme.
-
Bulk drug manufacturers seek support from govt, regulatory authorities
expresspharma
June 28, 2020
Indian bulk drug manufacturers have requested the government and regulating authorities to bring some changes in the existing policies along with regulatory reforms to uplift the country’s API industry and work towards Aatmanirbhar Bharat.